" /> Riviciclib Hydrochloride - CISMeF





Preferred Label : Riviciclib Hydrochloride;

NCIt definition : The hydrochloride salt form of riviciclib, a flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Riviciclib selectively binds to and inhibits Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, serine/threonine kinases that play key roles in the regulation of the cell cycle and cellular proliferation. Inhibition of these kinases leads to cell cycle arrest during the G1/S transition, thereby leading to an induction of apoptosis, and inhibition of tumor cell proliferation.;

UNII : DRP53ZDY6H;

InChIKey : OOVTUOCTLAERQD-OJMBIDBESA-N;

CAS number : 920113-03-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 920113-03-7 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

NCI Metathesaurus CUI : CL539515;

Details


You can consult :


Nous contacter.
07/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.